Literature DB >> 17899169

Endothelial function in aorta segments of apolipoprotein E-deficient mice before development of atherosclerotic lesions.

Paul Fransen1, Tim Van Assche, Pieter-Jan Guns, Cor E Van Hove, Gilles W De Keulenaer, Arnold G Herman, Hidde Bult.   

Abstract

Acetylcholine (ACh)-induced relaxation declines in apolipoprotein E-deficient (apoE-/-) mouse aortas, but only after atherosclerotic plaque formation. This study investigated intracellular calcium concentrations [Ca2+]i and changes in phenylephrine-induced contractions as index of baseline nitric oxide (NO) bioavailability before plaque development. Isometric contractions of thoracic aorta rings of young (4 months) apoE-/- and C57BL/6J (WT) mice were evoked by phenylephrine (3x10(-9)-3x10(-5) M) in the presence and absence of endothelial cells (ECs) or NO synthase (NOS) inhibitors. [Ca2+]i (Fura-2 AM) and endothelium-dependent relaxation were measured at baseline and after ACh stimulation. Segments of apoE-/- mice were significantly more sensitive and developed more tension than WT segments in response to phenylephrine. The differences disappeared after NOS inhibition or EC removal or upon increasing [Ca2+]i in apoE-/- strips with 10(-6) M cyclopiazonic acid or 10(-7) M Ca2+-ionophore A23187. Expression of endothelial NOS (eNOS) mRNA was similar in apoE-/- and WT aorta segments. Basal [Ca2+]i was significantly lower in apoE-/- than in WT strips. Relaxation by ACh (3x10(-9)-10(-5) M) was time- and dose-dependently related to [Ca2+]i, but neither ACh-induced relaxation nor Ca2+ mobilization were diminished in apoE-/- strips. In conclusion, basal, but not ACh-induced NO bioavailability, was compromised in lesion-free aorta of apoE-/- mice. Decreased basal NO bioavailability was not related to lower eNOS expression, but most likely related to lower basal [Ca2+]i. These findings further point to important differences between basal and stimulated eNOS activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17899169     DOI: 10.1007/s00424-007-0337-9

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  34 in total

1.  A Unique Role of NO in the Control of Blood Flow.

Authors:  Ulrich Pohl; Cor de Wit
Journal:  News Physiol Sci       Date:  1999-04

Review 2.  Malfunction of vascular control in lifestyle-related diseases: endothelial nitric oxide (NO) synthase/NO system in atherosclerosis.

Authors:  Seinosuke Kawashima
Journal:  J Pharmacol Sci       Date:  2004-12       Impact factor: 3.337

3.  Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice.

Authors:  K Kauser; V da Cunha; R Fitch; C Mallari; G M Rubanyi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-05       Impact factor: 4.733

4.  Ca2+ mobilization in the aortic endothelium in streptozotocin-induced diabetic and cholesterol-fed mice.

Authors:  K Kamata; M Nakajima
Journal:  Br J Pharmacol       Date:  1998-04       Impact factor: 8.739

5.  Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse.

Authors:  Y Nakashima; E W Raines; A S Plump; J L Breslow; R Ross
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-05       Impact factor: 8.311

6.  Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization.

Authors:  J Liu; G García-Cardeña; W C Sessa
Journal:  Biochemistry       Date:  1996-10-15       Impact factor: 3.162

Review 7.  Aging and vascular responsiveness.

Authors:  P M Vanhoutte
Journal:  J Cardiovasc Pharmacol       Date:  1988       Impact factor: 3.105

8.  Reduced responsiveness of hypercholesterolemic rabbit aortic smooth muscle cells to nitric oxide.

Authors:  R M Weisbrod; M C Griswold; Y Du; V M Bolotina; R A Cohen
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-02       Impact factor: 8.311

9.  Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice.

Authors:  M Barton; C C Haudenschild; L V d'Uscio; S Shaw; K Münter; T F Lüscher
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

10.  Reduction of blood pressure, plasma cholesterol, and atherosclerosis by elevated endothelial nitric oxide.

Authors:  Rien van Haperen; Monique de Waard; Elza van Deel; Barend Mees; Michael Kutryk; Thijs van Aken; Jaap Hamming; Frank Grosveld; Dirk J Duncker; Rini de Crom
Journal:  J Biol Chem       Date:  2002-10-02       Impact factor: 5.157

View more
  16 in total

1.  Vascular hypercontractility and endothelial dysfunction before development of atherosclerosis in moderate dyslipidemia: role for nitric oxide and interleukin-6.

Authors:  Vanessa Cavieres; Karla Valdes; Brayan Moreno; Rodrigo Moore-Carrasco; Daniel R Gonzalez
Journal:  Am J Cardiovasc Dis       Date:  2014-10-11

2.  Decreased production of neuronal NOS-derived hydrogen peroxide contributes to endothelial dysfunction in atherosclerosis.

Authors:  L S A Capettini; S F Cortes; J F Silva; J I Alvarez-Leite; V S Lemos
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

3.  Alterations in nitric oxide and endothelin-1 bioactivity underlie cerebrovascular dysfunction in ApoE-deficient mice.

Authors:  Kazuo Yamashiro; Alexandra B Milsom; Johan Duchene; Catherine Panayiotou; Takao Urabe; Nobutaka Hattori; Amrita Ahluwalia
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-17       Impact factor: 6.200

4.  Correction of endothelial dysfunction after selective homocysteine lowering gene therapy reduces arterial thrombogenicity but has no effect on atherogenesis.

Authors:  Frank Jacobs; Eline Van Craeyveld; Ilayaraja Muthuramu; Stephanie C Gordts; Jan Emmerechts; Marc Hoylaerts; Paul Herijgers; Bart De Geest
Journal:  J Mol Med (Berl)       Date:  2011-06-18       Impact factor: 4.599

5.  Differential effects of medroxyprogesterone acetate on thrombosis and atherosclerosis in mice.

Authors:  Till Freudenberger; Marc Oppermann; Andrea Marzoll; Hans-Karl Heim; Peter Mayer; Georg Kojda; Artur A Weber; Karsten Schrör; Jens W Fischer
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

6.  Lipid lowering and HDL raising gene transfer increase endothelial progenitor cells, enhance myocardial vascularity, and improve diastolic function.

Authors:  Stephanie C Gordts; Eline Van Craeyveld; Ilayaraja Muthuramu; Neha Singh; Frank Jacobs; Bart De Geest
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

Review 7.  Endothelial dysfunction in the apolipoprotein E-deficient mouse: insights into the influence of diet, gender and aging.

Authors:  Silvana S Meyrelles; Veronica A Peotta; Thiago M C Pereira; Elisardo C Vasquez
Journal:  Lipids Health Dis       Date:  2011-11-14       Impact factor: 3.876

8.  Atherosclerosis affects calcium signalling in endothelial cells from apolipoprotein E knockout mice before plaque formation.

Authors:  Clodagh Prendergast; John Quayle; Theodor Burdyga; Susan Wray
Journal:  Cell Calcium       Date:  2014-02-22       Impact factor: 6.817

9.  Atherosclerosis differentially affects calcium signalling in endothelial cells from aortic arch and thoracic aorta in Apolipoprotein E knockout mice.

Authors:  Clodagh Prendergast; John Quayle; Theodor Burdyga; Susan Wray
Journal:  Physiol Rep       Date:  2014-10-24

10.  Gal-geun-dang-gwi-tang improves diabetic vascular complication in apolipoprotein E KO mice fed a western diet.

Authors:  So Min Lee; Yun Jung Lee; Jung Hoon Choi; Min Chul Kho; Jung Joo Yoon; Sun Ho Shin; Dae Gill Kang; Ho Sub Lee
Journal:  BMC Complement Altern Med       Date:  2014-11-22       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.